Minority Affairs Committee Fall 2014.  Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee.

Slides:



Advertisements
Similar presentations
David Taber, Charles Bratton, Angello Lin, John McGillicuddy, Kenneth Chavin and Prabhakar Baliga.
Advertisements

Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Diabetes Disparities & Its Effects on Minority Populations Appathurai Balamurugan, MD, MPH Section Chief, Chronic Disease Epidemiology, ADHHS Assistant.
Tasks and responsibilities of the German organ procurement organization DSO Technical Assistance for Alignment in Organ Donation 1st International Symposium.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
Recognizing Seasonal and Geographically Endemic Infections in Organ Donors: Considerations during Living Donor Evaluation (Resolution 16) Ad Hoc Disease.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
Todd Franzen, MPA Community Relations Team Leader.
Taskforce Implementation – Progress and Results Chris Rudge FRCS National Clinical Director for Transplantation Renal CDs Meeting 12 March 2010.
Quality Assessment of Your Donor Program Clinton Coil, MD, Patient Safety Officer Laura Schneider, RN, BSN, Trauma Program Manager Susan Black, RNP, MSN,
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
A Panel Discussion The Donation and Transplantation Symposium October 15, 2013 Presenters: Amy Durrant, OneLegacy Ambassador & Donor Wife Robert Coppel,
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
PAIRED EXCHANGE KIDNEY TRANSPLANTATION EXPERIENCE OF TURKEY Levent Yucetin MD. Antalya Medicalpark Healthcare Group Transplant Center Senior Transplant.
Low Health Literacy Poor Relationships with Providers Historical Racism in Medical Care Socioeconomic Status Insurance Coverage Religious Beliefs Poor.
OPTN Patient Affairs Committee Regional Presentation Spring 2011 Laura Ellsworth - Chair Kristie Lemmon – Vice Chair.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
CEO Report UW Hospital and Clinics Authority Board Donna Katen-Bahensky President and CEO UW Hospital and Clinics July 7, 2010.
Proposal To Modify Existing or Establish New Requirements for the Psychosocial and Medical Evaluation of all Living Donors Living Donor Committee Spring.
OPTN Strategic Plan Maureen McBride United Network for Organ Sharing August 28, 2012.
Child Development Infoline/United Way of CT 7/1/02-6/30/03 Who called the Child Development Infoline (CDI)? Birth to ThreeHelp Me GrowPreschool Special.
Who we are What we do Where we are going How you can help.
PATIENT AFFAIRS COMMITTEE Regional Presentation – Fall 2012.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
OPTN Minority Affairs Committee Update March 13, 2012 Meeting Chicago O’Hare Hilton.
1 Proposal to Increase Committee Terms to Three Years Policy Oversight Committee (POC) Fall 2015.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
Proposal to Notify Patients Having an Extended Inactive Status Transplant Coordinators Committee Spring 2014.
Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Minority Affairs Committee Update 2012 Fall Regional Meetings.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
1 Vascularized Composite Allograft (VCA) Transplantation Committee Fall 2015 Update.
Are We Still Worlds Apart? Racial and ethnic disparities in kidney transplantation November 16, 2015 Vanessa Grubbs, MD, MPH Assistant Professor Division.
Guidance for VCA Deceased Donor Authorization (Resolution 7)
White Paper: Ethical Considerations of Imminent Death Donation
Minority Affairs Committee
2017 Annual Data Report Healthy People 2020.
Number of transplants, by donor type figure 8.1
Guidance on Optimizing VCA Recovery from Deceased Donors
Vascularized Composite Allograft (VCA) Transplantation Committee
2018 Annual Data Report Volume 3: Healthy People 2020
Gaining Informed Transfusion Consent
Your ethnic background influences your genetic make up - that means you’re more likely to be a matching donor for someone who shares your ethnic heritage.
Patient Affairs Committee
Pediatric Transplantation Committee
Patient Affairs Committee
Patient Affairs Committee
Minority Affairs Committee Update
Transplant Administrators Committee (TAC)
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Pediatric Transplantation Committee
Living Donor Committee
OPTN/UNOS Ethics Committee
Living Donation & Transplantation
Living Donor Committee Spring 2014
Minority Affairs Committee
Patient Affairs Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Minority Affairs Committee Update
Living Donor Committee Spring 2014
Minority Affairs Committee Update
Patient characteristics: American vs Canadian transplant patients
Living Donor Committee
Patient Affairs Committee
White Paper: Split Versus Whole Liver Transplantation
Presentation transcript:

Minority Affairs Committee Fall 2014

 Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee  Based on research from the MAC Early Referral Guidance Document  Targeted for primary care providers, internists, nephrologists and dialysis centers Patients Guide to Kidney Transplant Referral

 Black and male living kidney donors are at a higher risk than white and female living kidney donors to develop ESRD following kidney donation.  Vulnerable populations need to know the risk of living donation  Committee is developing guidance on informed consent for living donors at greater risk Informed Consent for Living Donors-Vulnerable Populations

Patient Affairs Chair Meelie Debroy, MD UNOS Staff Liaison Freda Wilkins Questions?